Open Access iconOpen Access

REVIEW

crossmark

Clinical implications of single cell sequencing for bladder cancer

REZA YADOLLAHVANDMIANDOAB1,#, MEHRSA JALALIZADEH1,#, FRANCIELE APARECIDA VECHIA DIONATO1, KEINI BUOSI1, PATRÍCIA A. F. LEME1, LUCIANA S. B. DAL COL1, CRISTIANE F. GIACOMELLI1, ALEX DIAS ASSIS1, NASIM BASHIRICHELKASARI1, LEONARDO OLIVEIRA REIS1,2,*

1 UroScience, School of Medical Sciences, University of Campinas, UNICAMP, Campinas, Sao Paulo, 13083-872, Brazil
2 ImmunOncology, Pontifical Catholic University of Campinas, PUC-Campinas, Campinas, Sao Paulo, 13087-571, Brazil

* Corresponding Author: LEONARDO OLIVEIRA REIS. Email: email
# These authors contributed equally

Oncology Research 2024, 32(4), 597-605. https://doi.org/10.32604/or.2024.045442

Abstract

Bladder cancer (BC) is the 10th most common cancer worldwide, with about 0.5 million reported new cases and about 0.2 million deaths per year. In this scoping review, we summarize the current evidence regarding the clinical implications of single-cell sequencing for bladder cancer based on PRISMA guidelines. We searched PubMed, CENTRAL, Embase, and supplemented with manual searches through the Scopus, and Web of Science for published studies until February 2023. We included original studies that used at least one single-cell technology to study bladder cancer. Forty-one publications were included in the review. Twenty-nine studies showed that this technology can identify cell subtypes in the tumor microenvironment that may predict prognosis or response to immune checkpoint inhibition therapy. Two studies were able to diagnose BC by identifying neoplastic cells through single-cell sequencing urine samples. The remaining studies were mainly a preclinical exploration of tumor microenvironment at single cell level. Single-cell sequencing technology can discriminate heterogeneity in bladder tumor cells and determine the key molecular properties that can lead to the discovery of novel perspectives on cancer management. This nascent tool can advance the early diagnosis, prognosis judgment, and targeted therapy of bladder cancer.

Graphical Abstract

Clinical implications of single cell sequencing for bladder cancer

Keywords


Supplementary Material

Supplementary Material File

Cite This Article

APA Style
YADOLLAHVANDMIANDOAB, R., JALALIZADEH, M., DIONATO, F.A.V., BUOSI, K., LEME, P.A.F. et al. (2024). Clinical implications of single cell sequencing for bladder cancer. Oncology Research, 32(4), 597-605. https://doi.org/10.32604/or.2024.045442
Vancouver Style
YADOLLAHVANDMIANDOAB R, JALALIZADEH M, DIONATO FAV, BUOSI K, LEME PAF, COL LSBD, et al. Clinical implications of single cell sequencing for bladder cancer. Oncol Res. 2024;32(4):597-605 https://doi.org/10.32604/or.2024.045442
IEEE Style
R. YADOLLAHVANDMIANDOAB et al., "Clinical implications of single cell sequencing for bladder cancer," Oncol. Res., vol. 32, no. 4, pp. 597-605. 2024. https://doi.org/10.32604/or.2024.045442



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 839

    View

  • 223

    Download

  • 1

    Like

Share Link